World

Russia won't comment publicly on the latest peace proposal

Dec 25, 2025

Moscow [Russia], December 25: Russia plans to relay its response to the latest draft of a Ukraine peace plan to Washington in the near future, the Kremlin said on Wednesday.
Russian President Vladimir Putin has been briefed following talks between US and Russian negotiators in Miami last weekend, his spokesman Dmitry Peskov was quoted as saying by Russia's Interfax news agency. Russia is now drafting its position while remaining in contact with US officials, Peskov said, stressing that Moscow would not publicly comment on aspects of the plan that have yet to be resolved.
Russia's position has long been known to the US, he added.
The comments came after Ukrainian President Volodymyr Zelensky on Wednesday revealed a US-backed 20-point plan to end Russia's war against his country.
The plan includes proposed Western security guarantees for Ukraine modelled on NATO's collective defence clause, while setting the size of Ukraine's armed forces at 800,000 troops.
Zelensky told journalists that while Kiev, the US and Europe had reached consensus on several major issues, the main sticking point continues to be territorial control over eastern Ukraine.
Russia has long demanded that Kiev cede control over the eastern region of Donetsk in exchange for a ceasefire.
Source: Qatar Tribune

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026